SUNLENCA vs YEZTUGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Attribute	SUNLENCA	YEZTUGO
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LENACAPAVIR SODIUM	LENACAPAVIR SODIUM
Manufacturer	Gilead Sciences Inc	Gilead Sciences Inc
Dosage forms	Tablet, Kit	Tablet, Kit
Drug class	—	—
Boxed warning	None	Boxed warning
Half-life	about 10 to 12 days after an oral dose; about 8 to 12 weeks after the subcutaneous injection	about 10 to 12 days after an oral dose; about 8 to 12 weeks after the subcutaneous injection

sunlenca yeztugo

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

LENACAPAVIR SODIUM

Manufacturer

Gilead Sciences Inc

Dosage forms

Tablet, Kit

Drug class

—

Boxed warning

None

Boxed warning

Half-life

about 10 to 12 days after an oral dose; about 8 to 12 weeks after the subcutaneous injection

Frequently asked questions

Which is better-rated, Sunlenca or Yeztugo?

Sunlenca and Yeztugo are tied at 3.6 out of 5 by our independent rating.

What is the difference between Sunlenca and Yeztugo?

Both Sunlenca and Yeztugo share the active ingredient Lenacapavir Sodium.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.